Clinical significance of growth differentiation factor-15 in patients with type 2 diabetes for early detection of cardiac complications

被引：0
|
作者：
Yankova, L. [1 ]
Gorcheva, D. [2 ]
Koleva, V. [1 ]
Tihomirova, V. [1 ]
Lozanov, L. [2 ]
机构：
[1] Acibadem City Clin Univ Hosp Tokuda, Clin Lab Dept, Sofia, Bulgaria
[2] Acibadem City Clin Univ Hosp Tokuda, Dept Endocrinol, Sofia, Bulgaria
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118233
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1587
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update
    Arkoumani, Maria
    Papadopoulou-Marketou, Nektaria
    Nicolaides, Nicolas C.
    Kanaka-Gantenbein, Christina
    Tentolouris, Nikolaos
    Papassotiriou, Ioannis
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2020, 57 (02) : 114 - 125
  • [42] Growth Differentiation Factor-15 and Clinical Outcomes in Lower Extremity Artery Disease
    Shikama, Taku
    Otaki, Yoichiro
    Watanabe, Tetsu
    Tamura, Harutoshi
    Kato, Shigehiko
    Nishiyama, Satoshi
    Takahashi, Hiroki
    Arimoto, Takanori
    Watanabe, Masafumi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (06) : 964 - 978
  • [43] Relationship between plasma growth differentiation factor-15 level and estimated glomerular fi ltration rate in type 2 diabetes patients with and without albuminuria
    Chung, Jin Ook
    Chung, Min Young
    Park, Seon-Young
    Cho, Dong Hyeok
    Chung, Dong Jin
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (04)
  • [44] Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study
    Natali, Andrea
    Nesti, Lorenzo
    Venturi, Elena
    Shore, Angela C.
    Khan, Faisel
    Gooding, Kim
    Gates, Phillip E.
    Looker, Helen C.
    Dove, Fiona
    Goncalves, Isabel
    Persson, Margaretha
    Nilsson, Jan
    DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 412 - 416
  • [45] Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15
    Berezin, Alexander E.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (01) : S154 - S157
  • [46] Growth-differentiation factor-15 in the early diagnosis and risk stratification of patients with acute chest pain
    Drexler, B.
    Reichlin, T.
    Schaub, N.
    Twerenbold, R.
    Reiter, M.
    Steuer, S.
    Bassetti, S.
    Winkler, K.
    Osswald, S.
    Mueller, C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 424 - 424
  • [47] ASSESSMENT OF SERUM TENASCIN-C AND GROWTH DIFFERENTIATION FACTOR-15 AMONG TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROME
    Vasanthi, Murugaiyan
    Adole, Prashant
    Pandit, Vinay
    Vinod, Kolar
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (04) : 460 - 466
  • [48] Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy
    Foley, Paul W. X.
    Stegemann, Berthold
    Ng, Kelvin
    Ramachandran, Sud
    Proudler, Anthony
    Frenneaux, Michael P.
    Ng, Leong L.
    Leyva, Francisco
    EUROPEAN HEART JOURNAL, 2009, 30 (22) : 2749 - 2757
  • [49] Growth-differentiation Factor-15: a Novel Biomarker in Patients with Diastolic Dysfunction?
    Dinh, Wilfried
    Fueth, Reiner
    Lankisch, Mark
    Hess, Georg
    Zdunek, Dietmar
    Scheffold, Thomas
    Kramer, Frank
    Klein, Rolf Michael
    Barroso, Michael Coll
    Nickl, Werner
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (01)
  • [50] Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD
    Husebo, Gunnar R.
    Gronseth, Rune
    Lerner, Lorena
    Gyuris, Jeno
    Hardie, Jon A.
    Bakke, Per S.
    Eagan, Tomas M.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
12345